GoodRx Holdings, Inc. (GDRX) Financial Statements
Industry: Computer Processing & Data Preparation (Services)
In fiscal 2025, GoodRx reported revenue of $796.9M, up 0.6% from $792.3M the year before. Net income was $30.4M (a 3.8% net margin), or $0.09 per diluted share. Gross margin was 11.0% and operating margin was 11.0%. Operating activities generated $167.9M of cash, leaving $164.4M of free cash flow. At fiscal year end, GoodRx held $1.40B in total assets against $787.8M in total liabilities, including $261.8M of cash and equivalents.
Open the full interactive GoodRx financials → Quarterly statements, key ratios, valuation history and price charts.
GoodRx Key Stats
| Share Price | $3.45 |
|---|---|
| Market Cap | $1.20B |
| P/E Ratio | 38.3 |
| Revenue YoY Growth | +0.6% |
| 52-Week Range | $1.87 – $4.16 |
| Shares Outstanding | 339.3 million (basic, 2026 Q2) |
GoodRx Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $550.7M | $745.4M | $766.6M | $750.3M | $792.3M | $796.9M |
| Cost of Goods Sold | $826.4M | $732.0M | $764.8M | $777.3M | $726.5M | $709.4M |
| Gross Profit | -$275.7M | $13.4M | $1.7M | -$27.0M | $65.8M | $87.5M |
| Operating Income | -$275.7M | $13.4M | $1.7M | -$27.0M | $65.8M | $87.5M |
| Pre-Tax Income | -$303.4M | -$10.2M | -$23.2M | -$55.6M | $31.5M | $56.5M |
| Income Tax | -$9.8M | $15.1M | $9.6M | -$46.7M | $15.1M | $26.1M |
| Net Income | -$293.6M | -$25.3M | -$32.8M | -$8.9M | $16.4M | $30.4M |
| Diluted EPS | -$1.07 | -$0.06 | -$0.08 | -$0.02 | $0.04 | $0.09 |
GoodRx Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $196.0M | $194.8M | $194.0M | $200.4M |
| Net Income | $1.1M | $5.4M | $1.2M | $8.5M |
| Diluted EPS | — | $0.02 | — | $0.02 |
GoodRx Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $968.7M | $941.1M | $757.2M | $672.3M | $448.3M | $261.8M |
| Current Assets | $1.09B | $1.09B | $919.7M | $872.8M | $659.3M | $643.1M |
| Total Assets | $1.47B | $1.61B | $1.60B | $1.59B | $1.39B | $1.40B |
| Current Liabilities | $59.6M | $81.1M | $76.3M | $122.6M | $123.9M | $246.0M |
| Total Long-Term Debt | $666.9M | $662.9M | $658.8M | $656.5M | $491.7M | $488.3M |
| Total Liabilities | $758.8M | $775.9M | $789.8M | $826.8M | $663.4M | $787.8M |
| Shareholders' Equity | $711.4M | $831.7M | $814.8M | $762.0M | $724.7M | $616.3M |
GoodRx Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $131.3M | $178.8M | $146.8M | $138.3M | $183.9M | $167.9M |
| Cash From Investing | -$91.6M | -$178.7M | -$210.5M | -$55.8M | -$70.3M | -$120.0M |
| Cash From Financing | $905.8M | -$30.5M | -$120.2M | -$167.4M | -$337.5M | -$234.5M |
| Free Cash Flow | $110.8M | $174.2M | $142.8M | $137.2M | $182.7M | $164.4M |
Figures from GoodRx's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full GoodRx financials page for every line item.
GoodRx Company Profile
| Ticker | GDRX |
|---|---|
| Exchange | Nasdaq |
| Industry | Computer Processing & Data Preparation (Services) |
| Headquarters | Santa Monica, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001809519 |
Frequently Asked Questions
What was GoodRx's revenue in fiscal 2025?
GoodRx (GDRX) reported revenue of $796.9M for fiscal 2025.
What is GoodRx's annual revenue history?
GoodRx's annual revenue by fiscal year: 2020: $550.7M; 2021: $745.4M; 2022: $766.6M; 2023: $750.3M; 2024: $792.3M; 2025: $796.9M.
What was GoodRx's net income in fiscal 2025?
GoodRx reported net income of $30.4M for fiscal 2025.
What was GoodRx's earnings per share (EPS) in fiscal 2025?
GoodRx's diluted EPS was $0.09 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did GoodRx generate in fiscal 2025?
GoodRx generated $164.4M of free cash flow in fiscal 2025.
What was GoodRx's revenue last quarter?
In its most recent reported quarter (2026 Q2), GoodRx reported revenue of $200.4M.
How much debt does GoodRx have?
GoodRx reported $488.3M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of GoodRx are outstanding?
GoodRx reported a weighted average of 339.3 million basic shares outstanding in 2026 Q2.
What is GoodRx's market cap?
Based on its latest closing price, GoodRx (GDRX) has a market capitalization of about $1.20B.
When does GoodRx's fiscal year end?
GoodRx's fiscal year end, as registered with the SEC, is December 31.
Where is GoodRx headquartered?
GoodRx lists its business address in Santa Monica, California in its SEC filings.